Some news today regarding Biogen and its contentious $56,000 Alzheimer’s drug.
$9 billion USD in revenue by 2027. That give you an idea of the stakes we are playing for. And that's just for Alzheimers. A billion dollar buy-out would be nothing for Big Pharma.
I'm am hodling with diamond hands.
LINK:
https://finance.yahoo.com/news/biogen-20-billion-slide-wipes-143249969.html
Potential 100 bagger Biotech missed by the market, page-1224
-
- There are more pages in this discussion • 295 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.494M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 232982 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 199999 | 1 |
View Market Depth
| Last trade - 10.06am 15/08/2024 (20 minute delay) ? |
| NSB (ASX) Chart |
Day chart unavailable